VALERO ENERGY CORP/TX
VLO · NYSE · CIK 0001035002
SIC 2911
Petroleum Refining
Category
Energy
Entity
operating
Incorp.
DE
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$312.90
+1.19 (+0.38%)
Open
$312.33
High
$314.85
Low
$306.27
Prev Close
$311.71
Volume
2,385,738
52W High
$262.50
52W Low
$121.98
50-day MA
$242.34
Quote as of: 2026-07-31
ROE
9.90%
Total Shareholder Yield
5.44%
Market Cap
$73.33B
P/E
18.05
P/B
3.07
PEG
4.08
EPS
13.68
BPS
79.36
Dividend Yield
1.90%
Beta
0.57
ROA
4.05%
Current Ratio
1.65
Gross Margin
-0.19%
Operating Margin
2.59%
Net Margin
1.91%
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (7 methods)
$35.40B
Per-method implied market cap
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $35.40B | +107% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $19.96B | +267% |
Justified P/E 순이익 × 산업 평균 P/E | $35.22B | +108% |
P/B 배수 자본 × 산업 평균 P/B | $35.59B | +106% |
P/S 배수 매출 × 산업 평균 P/S | $245.37B | -70% |
DCF (Gordon) CF × (1+g) / (r − g) | $64.73B | +13% |
DDM (Gordon) D × (1+g) / (r − g) | $15.61B | +370% |
▶Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +107.1% below the current market cap → the stock trades above most formulas' estimates (overvalued). 5 methods flag overvalued, 1 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +107.1%√(22.5 × 순이익 × 자본)
What it measures · Benjamin Graham's conservative safety-margin formula. A high value requires both earnings and equity to be solid, so read it as 'the ceiling for a financially intact company.'
How it is computed · √(22.5 × NetIncome × Equity). 22.5 = max P/E 15 × max P/B 1.5 Graham would pay. Net income is latest FY consolidated net income from DART/XBRL; equity is total equity from the same filing.
When to trust it · Best for stable profitable industrials. Underestimates SaaS/platform/biotech because intangible-heavy businesses carry little book equity.
Current
$73.33B
Implied fair
$35.40B
Gap (current − fair)
+$37.93B(+107.1%)
NetIncome = $2.35B Equity = $23.73B √(22.5 × $2.35B × $23.73B) = $35.40B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Overvalued +267.4%순이익 × (8.5 + 2 × 성장률%)
What it measures · Graham's 1962 revision that bakes growth into the multiple. Unlike the static Graham Number, this scales linearly with EPS growth so growth stocks aren't punished as hard.
How it is computed · NetIncome × (8.5 + 2g). 8.5 = base P/E for a zero-growth firm; 2g = +2× P/E for every 1pp of EPS growth. g is YoY EPS growth, clamped to [-5%, +25%] so a single big year doesn't blow up the estimate.
When to trust it · Works for firms with proven, somewhat stable growth. Misleading for first-year profits, swing years, or any period where g is distorted by a one-time charge or gain.
Current
$73.33B
Implied fair
$19.96B
Gap (current − fair)
+$53.37B(+267.4%)
NetIncome = $2.35B Growth g = -15.2% → cap -5.0% Multiple = 8.5 + 2 × -5.0 = -1.5× $2.35B × -1.5 = $-3.52B
- EPS 성장률 -15.2%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 8.5x
Justified P/E
Overvalued +108.2%순이익 × 산업 평균 P/E
What it measures · Relative-value benchmark — "should trade at the industry average P/E." Not an absolute intrinsic value; tells you how the firm prices vs its peer set.
How it is computed · NetIncome × industry P/E. Defaults to a market-wide 15× when no industry multiple is provided. Net income is the latest FY consolidated net income.
When to trust it · Most reliable in mature industries with comparable peers (banks, telcos, utilities, refiners). Less useful for big-tech / hardware where industry P/Es span 10×–60×.
Current
$73.33B
Implied fair
$35.22B
Gap (current − fair)
+$38.11B(+108.2%)
NetIncome = $2.35B Industry P/E = 15× $2.35B × 15 = $35.22B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +106.1%자본 × 산업 평균 P/B
What it measures · Multiplies book equity by industry P/B to imply a fair market cap. Best for asset-heavy businesses (banks, insurers, brokers, REITs) where balance-sheet value is the franchise.
How it is computed · Total Equity × industry P/B. Defaults to 1.5×. Equity is total equity (or parent-owners share) from the latest balance sheet.
When to trust it · Strongest for banks/insurers — asset-liability matching is the business. Materially under-prices SaaS, platforms, and brand-heavy businesses where intangible value dwarfs book equity.
Current
$73.33B
Implied fair
$35.59B
Gap (current − fair)
+$37.74B(+106.1%)
Equity = $23.73B Industry P/B = 1.5× $23.73B × 1.5 = $35.59B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Undervalued -70.1%매출 × 산업 평균 P/S
What it measures · Multiplies revenue by industry P/S. Useful when earnings are negative or noisy (early-stage, restructuring) — revenue stays positive.
How it is computed · Revenue × industry P/S. Defaults to 2.0×. Revenue is the latest FY consolidated top line.
When to trust it · Ignores margin structure — a 30% operating margin business and a -5% one get the same multiple. Only meaningful within peer + margin cohort.
Current
$73.33B
Implied fair
$245.37B
Gap (current − fair)
$-172.04B(-70.1%)
Revenue = $122.69B Industry P/S = 2× $122.69B × 2 = $245.37B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Fair +13.3%CF × (1+g) / (r − g)
What it measures · Simplified Gordon-growth DCF — discounting perpetual cash flows. Extremely sensitive to the cash-flow / discount-rate / growth-rate inputs; trust the scenario grid more than the headline number.
How it is computed · FCF × (1+g) / (r − g). FCF preferred from XBRL/DART; falls back to NetIncome, then 5% of Revenue (rough proxy). Discount rate r = risk-free (4%) + equity premium (5%) = 9%. Growth g is EPS YoY clamped to [-2%, +6%], default 3%.
When to trust it · Strongest for steady, predictable businesses. When r-g approaches 0, the denominator blows up; near-perpetuity-growth combos are intentionally voided. Useless for cyclicals (semis, commodities, shipping) where g itself is noise.
Current
$73.33B
Implied fair
$64.73B
Gap (current − fair)
+$8.60B(+13.3%)
FCF = $5.83B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $5.83B × (1 + -2.0%) / (9.0% − -2.0%) = $51.90B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)
DDM (Gordon)
Overvalued +369.7%D × (1+g) / (r − g)
What it measures · Values the firm purely on dividends paid to shareholders. Cleanest in theory, but only meaningful when management clearly intends to pay dividends — useless for share-repurchase-only payout policies.
How it is computed · D × (1+g) / (r − g). D from DART alotMatter (배당사항) or |CF dividendsPaid|. If absent, cascades to 30% of NetIncome (typical payout) → 30% of FCF → 1.5% of Revenue. r and g assumptions match DCF.
When to trust it · Most reliable for stable high-yielders (Korean utilities, tobacco, financial holdings). Sharply under-prices buyback-heavy firms (US big tech, parts of Korean IT) — look at the TSY column on the listing page to balance.
Current
$73.33B
Implied fair
$15.61B
Gap (current − fair)
+$57.72B(+369.7%)
Dividend D = $1.41B Discount r = 9.0% Growth g = -2.0% $1.41B × (1 + -2.0%) / (9.0% − -2.0%) = $12.52B
- 배당 입력: 실제 지급 배당
- 할인율 9.0%
- 배당 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | -25.2% | -12.8% | -0.3% | +12.2% | +24.6% |
| 2% | -38.3% | -26.0% | -13.6% | -1.3% | +11.1% |
| 3% | -51.1% | -38.9% | -26.7% | -14.5% | -2.2% |
| 4% | -63.7% | -51.6% | -39.5% | -27.4% | -15.3% |
| 5% | -76.0% | -64.0% | -52.1% | -40.1% | -28.1% |
DDM sensitivity: discount rate × dividend growth
Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +210.1% | +261.7% | +313.4% | +365.1% | +416.8% |
| 2% | +155.8% | +207.0% | +258.2% | +309.4% | +360.5% |
| 3% | +102.7% | +153.4% | +204.0% | +254.7% | +305.4% |
| 4% | +50.6% | +100.7% | +150.9% | +201.1% | +251.3% |
| 5% | -0.6% | +49.1% | +98.8% | +148.5% | +198.2% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Showing the latest 5 years only
17 years of financials are available for this stock. Unlock the remaining 12 years (10+ year history) with Pro.
Upgrade to Pro · $1.99/moIn USD millions (per-share figures shown directly) · Financials as of: 2026-02-25
핵심 지표 FY 2025
ROE
9.90%
총주주수익률
5.44%
PER
18.05
PBR
3.07
PSR
0.60
PEG
4.08
EV/EBITDA
24.00
배당수익률
1.90%
ROA
4.05%
유동비율
1.65
매출총이익률
-0.19%
영업이익률
2.59%
순이익률
1.91%
EPS
$13.68
BPS
$79.36
실적 추이
📄 SEC Filings
Quarterly Report
10-Q
2026-07-30
Open →
Current Report
FORM 8-K SECOND QUARTER 2026 EARNINGS RELEASE
2026-07-30
Open →
Current Report
8-K
2026-07-16
Open →
Current Report
8-K
2026-05-08
Open →
Quarterly Report
10-Q
2026-04-30
Open →
Current Report
FORM 8-K FIRST QUARTER 2026 EARNINGS RELEASE
2026-04-30
Open →
Proxy Statement
DEF 14A
2026-03-19
Open →
Current Report
8-K
2026-03-09
Open →
Annual Report
10-K
2026-02-25
Open →
Current Report
FORM 8-K FOURTH QUARTER 2025 EARNINGS RELEASE
2026-01-29
Open →
Current Report
8-K
2025-10-29
Open →
Quarterly Report
10-Q
2025-10-23
Open →
Current Report
FORM 8-K THIRD QUARTER 2025 EARNINGS RELEASE
2025-10-23
Open →
Current Report
8-K
2025-10-16
Open →
Current Report
8-K
2025-09-19
Open →
Quarterly Report
10-Q
2025-07-24
Open →
Current Report
FORM 8-K SECOND QUARTER 2025 EARNINGS RELEASE
2025-07-24
Open →
Current Report
8-K
2025-05-09
Open →
Quarterly Report
10-Q
2025-04-24
Open →
Current Report
FORM 8-K FIRST QUARTER 2025 EARNINGS RELEASE
2025-04-24
Open →
Current Report
8-K
2025-04-16
Open →
Other filings (79)
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-07-31
Open →
Insider Transaction
FORM 4
2026-06-30
Open →
144
xsl144X01/primary_doc.xml
2026-06-29
Open →
11-K
PREMCOR RETIREMENT SAVINGS PLAN 2025 FORM 11-K
2026-06-26
Open →
11-K
VALERO THRIFT PLAN 2025 FORM 11-K
2026-06-26
Open →
Insider Transaction
FORM 4
2026-06-18
Open →
144
xsl144X01/primary_doc.xml
2026-06-17
Open →
Insider Transaction
FORM 4
2026-05-20
Open →
144
xsl144X01/primary_doc.xml
2026-05-18
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
Insider Transaction
FORM 4
2026-05-07
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
ARS
ARS
2026-03-19
Open →
DEFA14A
DEFA14A
2026-03-19
Open →
Insider Transaction
FORM 4
2026-03-12
Open →
144
xsl144X01/primary_doc.xml
2026-03-12
Open →
144
xsl144X01/primary_doc.xml
2026-03-12
Open →
144
xsl144X01/primary_doc.xml
2026-03-11
Open →
424B5
424B5
2026-03-09
Open →
FWP
FWP
2026-03-05
Open →
424B5
424B5
2026-03-05
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-24
Open →
Insider Transaction
FORM 4
2026-02-05
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
3
FORM 3
2026-01-09
Open →
Insider Transaction
FORM 4
2025-12-18
Open →
Insider Transaction
FORM 4
2025-12-18
Open →
Insider Transaction
FORM 4
2025-11-24
Open →
144
xsl144X01/primary_doc.xml
2025-11-21
Open →
Insider Transaction
FORM 4
2025-11-06
Open →
Insider Transaction
FORM 4
2025-09-22
Open →
3
FORM 3
2025-09-22
Open →
11-K
PREMCOR RETIREMENT SAVINGS PLAN 2024 FORM 11-K
2025-06-20
Open →
11-K
VALERO THRIFT PLAN 2024 FORM 11-K
2025-06-20
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
Insider Transaction
FORM 4
2025-05-19
Open →
4/A
FORM 4/A
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
Insider Transaction
FORM 4
2025-05-08
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-04-30
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2025-04-24
Open →
DEFA14A
DEFA14A
2025-04-21
Open →